Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3015616	s-ipro	— (—)	433	528	100.00%	Distribution not available
3015616	s-ipro	mmol/l (mmol/l)	45	50	70.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Substance abuse, excluding more controls

335

52.88

307.65

1.3

1.0

2.34

—

mmol/l

—

Alcohol abuse, main dg, excluding more controls

147

79.03

275.57

1.5

1.0

2.80

—

mmol/l

—

Poisoning by medicine

166

29.06

249.19

1.5

1.1

2.56

—

mmol/l

—

Mood disorders, excluding more controls

223

20.95

207.37

1.4

1.0

1.95

—

mmol/l

—

Schizophrenia or delusion, excluding more controls

101

37.34

162.39

1.4

1.0

2.06

—

mmol/l

—

Personality disorders, excluding more controls

37.96

159.21

1.7

1.0

2.51

—

mmol/l

—

Any mental disorder

215

15.20

154.01

1.4

1.0

1.64

—

mmol/l

—

Anxiety (asthma-related co-morbidities)

134

20.79

150.76

1.5

1.1

2.41

—

mmol/l

—

Anxiety disorders, excluding more controls

159

18.23

150.20

1.5

1.0

2.45

—

mmol/l

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

30.12

89.22

2.1

1.4

2.34

—

mmol/l

—

Persons encountering health services in other circumstances

10.14

86.25

1.7

1.1

2.20

—

mmol/l

—

Specific personality disorders

10.68

81.04

1.7

1.2

2.55

—

mmol/l

—

Other anxiety disorders

111

129

7.66

75.20

1.5

1.1

2.10

—

mmol/l

—

All anxiety disorders

137

177

6.25

74.32

1.5

1.1

2.41

—

mmol/l

—

Other specified and unspecified personality disorders

16.47

52.15

1.7

1.3

3.06

—

mmol/l

—

Mental and behavioural disorders due to opioids

33.70

51.36

1.2

1.8

—

Traumatic subdural haemorrhage

17.99

49.00

1.1

1.2

—

mmol/l

—

Pneumonitis due to solids and liquids

15.56

46.02

1.1

1.3

—

mmol/l

—

Lung diseases due to external agents

9.59

35.02

1.1

1.3

—

mmol/l

—

Panic disorder

9.48

28.82

1.2

—

13.26

26.26

1.1

1.0

—

mmol/l

—

Dialysis, with operation codes

8.09

24.74

1.3

1.2

—

mmol/l

—

Fracture of lower leg, including ankle

233

3.38

22.12

1.3

2.26

2.14

mmol/l

—

Other maltreatment syndromes

15.65

19.38

1.1

1.7

—

Hypothyroidism (congenital or acquired)

12.46

18.93

1.1

1.0

—

mmol/l

—

Phobic anxiety disorders

7.37

17.35

1.1

1.3

—

mmol/l

—

Type 2 diabetes, wide definition

198

2.83

16.13

1.0

1.2

—

1.24

mmol/l

—

Hypothyroidism and >3 levothyroxin purchases

11.04

15.77

1.1

1.0

—

mmol/l

—

Hypothyroidism, levothyroxine purchases

11.04

15.77

1.1

1.0

—

mmol/l

—

Hypertensive diseases (excluding secondary)

119

3.28

15.34

1.3

—

2.33

mmol/l

—

7.80

15.28

1.1

1.2

—

mmol/l

—

Disorders of mineral metabolism

9.52

15.22

1.1

1.2

—

mmol/l

—

Hypertension, essential

203

2.64

14.97

1.2

—

2.29

mmol/l

—

Oxycodone

4.05

14.90

1.2

1.1

—

mmol/l

—

Hernia of abdominal wall, postoperative

6.17

14.18

1.2

1.1

—

Nephropathy related operations

5.71

13.66

1.4

1.2

—

mmol/l

—

Hypertension

205

2.51

13.17

1.2

—

2.29

mmol/l

—

Other and unspecified injuries of head

10.06

13.13

1.1

1.5

—

Post-traumatic stress disorder

10.04

13.13

1.3

—

Hypertensive diseases

207

2.49

12.93

1.2

—

2.29

mmol/l

—

Fracture of forearm

192

2.88

12.64

1.1

1.2

—

2.36

mmol/l

—

Nontraumatic intracranial haemmorrhage

5.01

12.38

1.0

1.2

—

mmol/l

—

Gastroduodenal ulcer

4.21

12.36

1.3

1.2

—

mmol/l

—

Injury of other and unspecified intrathoracic organs

7.25

12.27

1.3

1.4

—

mmol/l

—

Psychotic depression

26.80

12.04

1.2

1.0

—

mmol/l

—

Unspecified kidney failure

8.85

12.00

1.4

1.2

—

mmol/l

—

Type 2 diabetes

100

263

2.26

11.75

1.1

1.2

—

1.53

mmol/l

—

Traumatic subarachnoid haemorrhage

23.10

11.58

1.1

1.3

—

mmol/l

—

Non-invasive ventilation

17.77

11.17

1.1

—

Other symptoms and signs involving general sensations and perceptions

20.20

11.14

1.1

1.4

—

Status epilepticus

10.99

11.07

1.1

1.6

—

mmol/l

—

Gastric ulcer

4.90

10.71

1.3

1.2

—

Cardiac arrhythmias

143

2.73

10.55

1.1

1.5

—

1.66

mmol/l

—

Intracerebral haemorrhage

5.77

10.52

1.0

1.3

—

mmol/l

—

Speech and linguistic disorders, excluding more controls

26.46

10.40

1.0

—

Complications of surgical and medical care, not elsewhere classified

321

2.12

10.16

1.4

1.2

2.48

1.76

mmol/l

—

Atrial fibrillation and flutter with reimbursement

4.23

9.78

1.1

1.2

—

mmol/l

—

Monoamine oxidase A inhibitors

6.83

9.72

1.0

1.1

—

mmol/l

—

Thiamine deficiency

+∞

9.45

1.1

0.0

—

mmol/l

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

8.49

9.19

1.1

2.4

—

Hyperlipidaemia, other/unspecified

3.34

8.61

1.1

—

mmol/l

—

Early onset COPD, excluding more controls

3.94

8.57

1.2

—

mmol/l

—

Focal brain injury

8.49

8.46

1.0

1.2

—

mmol/l

—

Neuromuscular dysfunction of bladder

5.17

8.40

2.6

1.1

—

mmol/l

—

Type 2 diabetes, definitions combined

249

2.06

8.26

1.1

1.2

—

1.53

mmol/l

—

Other degenerative diseases of the nervous system

4.74

8.20

1.5

1.1

—

mmol/l

—

Type 2 diabetes, strict (exclude DM1)

253

2.03

7.95

1.1

1.2

—

1.53

mmol/l

—

Chronic kidney disease

3.41

7.86

1.1

—

mmol/l

—

Oesophageal varices

6.71

7.61

1.1

—

mmol/l

—

Social phobias

5.93

7.37

1.2

1.3

—

mmol/l

—

Toxic effect of organic solvents

+∞

7.35

3.3

0.0

—

mmol/l

—

Degeneration of the brain due to alcohol

15.91

7.24

1.7

1.3

—

mmol/l

—

Degeneration of nervous system due to alcohol

15.91

7.24

1.7

1.3

—

mmol/l

—

Disorders of calcium metabolism

6.90

7.15

1.0

1.2

—

mmol/l

—

Injuries involving multiple body regions

7.74

7.12

1.1

1.6

—

Dysphagia

3.76

7.06

1.1

1.2

—

mmol/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

4.85

6.92

1.3

1.2

—

Suppurative and necrotic conditions of lower respiratory tract

6.03

6.90

1.1

1.5

—

Dissociative [conversion] disorders

13.83

6.89

4.3

1.6

—

Type 2 diabetes, definitions combined, including avohilmo

252

1.93

6.63

1.1

1.2

—

1.53

mmol/l

—

Any dementia, excluding more controls

4.31

6.45

1.1

1.0

—

mmol/l

—

Fracture of neck

5.48

6.29

1.1

1.2

—

mmol/l

—

Episodal and paroxysmal disorders

101

296

1.75

5.90

1.6

1.2

1.82

2.43

mmol/l

—

Sequelae of injuries of head

5.52

5.81

1.0

1.5

—

mmol/l

—

Sequelae of cerebrovascular disease

2.76

5.67

1.0

1.2

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.44

5.57

1.1

1.3

—

1.66

mmol/l

—

Duodenal ulcer

4.25

5.55

1.2

1.3

—

mmol/l

—

Special screening examination for other diseases and disorders

5.25

5.52

1.1

—

Mental and behavioural disorders due to tobacco

4.50

5.51

1.0

1.3

—

Gout, strict definition

3.34

5.43

1.1

1.3

—

mmol/l

—

Alcoholic gastritis

16.21

5.42

2.1

1.4

—

mmol/l

—

COPD-related respiratory insufficiency

4.13

5.35

1.0

1.1

—

Unspecified event, undetermined intent

11.34

5.29

1.0

1.6

—

mmol/l

—

Folate deficiency anaemia

+∞

5.22

1.0

0.0

—

mmol/l

—

Agoraphobia

13.40

5.08

1.0

1.8

—

Diffuse brain injury

13.39

5.08

1.1

1.3

—

mmol/l

—

Cirrhosis of liver, NAS

5.02

4.78

1.0

1.1

—

mmol/l

—

Early onset COPD

2.64

4.64

1.2

—

mmol/l

—

Symptoms and signs concerning food and fluid intake

4.40

4.55

1.0

1.3

—

Smoking dependency

3.83

4.53

1.0

1.3

—

Implicit fungal Sepsis

10.06

4.52

1.1

1.3

—

Vocal cord dysfunction

13.01

4.38

1.1

1.2

—

mmol/l

—

Open wound of abdomen, lower back and pelvis

7.55

4.36

1.3

1.4

—

mmol/l

—

Acute gastritis

4.24

4.35

1.0

1.4

—

Gout, idiopatic and unspecified

2.59

4.29

1.1

1.2

—

mmol/l

—

Fungal Sepsis

8.93

4.28

1.1

1.2

—

Other diseases of pancreas

4.36

4.09

1.3

1.2

—

mmol/l

—

Acute posthaemorrhagic anaemia

10.04

4.01

1.0

1.7

—

Idiopathic gout

3.94

3.97

1.2

1.1

—

Gout, FINNGEN

105

2.38

3.96

1.2

—

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.64

3.92

1.0

1.2

—

Open wound of ankle and foot

3.43

3.90

1.1

1.3

—

mmol/l

—

Gout, unspecified

2.77

3.84

1.1

1.2

—

mmol/l

—

Hypothyroidism, drug reimbursement

8.17

3.83

1.0

—

Special screening examination for infectious and parasitic diseases

2.62

3.79

1.0

1.1

—

Conduct disorder

12.07

3.76

4.8

1.0

—

Degenerative diseases of the nervous system

2.64

3.68

1.4

1.0

—

mmol/l

—

Speech disturbances, not elsewhere classified

3.68

3.63

1.1

1.3

—

mmol/l

—

Undetermined asthma, excluding more controls

3.67

3.63

1.1

1.3

—

mmol/l

—

Undetermined asthma

3.67

3.63

1.1

1.3

—

mmol/l

—

Lesion of ulnar nerve

2.75

3.58

1.1

1.3

—

mmol/l

—

Fibrosis and cirrhosis of liver

3.86

3.52

1.0

1.3

—

mmol/l

—

Visual impairment including blindness (binocular or monocular)

5.31

3.51

1.3

1.4

—

mmol/l

—

Barrett oesophagus

6.18

3.50

1.8

1.2

—

mmol/l

—

Parodontitis or/and operation codes

192

1.73

3.46

1.1

1.2

—

2.45

mmol/l

—

Cardiomyopathy

2.66

3.39

1.4

1.3

—

mmol/l

—

!Aliquae complicationes praecoces traumatis

5.02

3.37

1.7

1.6

—

mmol/l

—

Early complications of trauma

5.02

3.37

1.7

1.6

—

mmol/l

—

Neuralgia and neuritis, unspecified

5.02

3.37

1.3

1.4

—

Unspecified jaundice

7.02

3.36

1.0

1.5

—

mmol/l

—

Pyothorax

5.36

3.19

1.1

1.5

—

Post-traumatic wound infection, not elsewhere classified

7.54

3.06

2.0

1.4

—

Extreme obesity with alveolar hypoventilation

5.02

3.05

1.1

1.6

—

mmol/l

—

Moderate visual impairment, binocular

10.04

2.98

1.4

1.0

—

mmol/l

—

Myalgia

2.47

2.95

1.1

1.3

—

Superficial injuries involving multiple body regions

6.70

2.87

1.2

1.9

—

Peripheral arterial reconstruction

2.93

2.85

1.0

1.2

—

Other or ill-defined heart diseases

4.45

2.79

1.3

1.6

—

Glomerular disorders in diseases classified elsewhere

2.86

2.74

1.0

1.2

—

mmol/l

—

Fibroblastic disorders

2.31

2.74

1.2

—

mmol/l

—

Mumps

6.03

2.70

1.0

1.5

—

Pneumonia derived septicemia

6.02

2.70

1.0

1.7

—

Haemorrhage from respiratory passages

103

2.07

2.68

1.1

—

mmol/l

—

Residual foreign body in soft tissue

4.22

2.68

1.0

1.4

—

Injury of eye and orbit

2.79

2.64

1.2

—

Hemiplegia

4.01

2.56

3.9

1.5

—

mmol/l

—

Burns and corrosions of multiple and unspecified body regions

7.18

2.55

1.0

—

Complications of other internal prosthetic devices, implants and grafts

7.16

2.55

1.2

1.0

—

mmol/l

—

Paralytic ileus

5.47

2.54

1.2

1.6

—

Hypertensive Heart Disease

2.55

2.51

1.0

1.1

—

Lesion of lateral popliteal nerve

3.82

2.46

1.0

1.5

—

mmol/l

—

Other respiratory diseases principally affecting the interstitium

2.55

2.44

1.2

—

mmol/l

—

Exposure to smoke, fire and flames

6.28

2.37

1.0

1.6

—

Vascular diseases of the intestine

6.26

2.37

1.2

1.3

—

Other diseases of intestine

2.75

2.37

1.5

1.3

—

Statin medication

211

1.54

2.37

1.2

—

2.45

mmol/l

—

Respiratory insufficiency

3.89

2.24

1.0

1.4

—

mmol/l

—

Generalized epilepsy, strict definition

5.58

2.21

2.0

1.9

—

Schizotypal disorder

5.58

2.21

1.0

1.6

—

Burns and corrosions confined to eye and internal organs

5.58

2.21

1.4

1.0

—

Somatoform disorder

2.62

2.18

1.2

—

mmol/l

—

ILD, hospital admission 2, with pulmonary infections

3.34

2.18

1.4

1.3

—

Other ill-defined and unspecified causes of mortality

4.29

2.15

1.2

1.1

—

mmol/l

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

4.30

2.15

1.0

1.1

—

Diabetic nephropathy, excluding more controls

2.19

2.13

1.0

1.2

—

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

104

1.88

2.09

1.2

—

mmol/l

—

ILD, hospital admissions

2.56

2.09

1.3

1.2

—

mmol/l

—

Interstitial lung disease

2.56

2.09

1.3

1.2

—

mmol/l

—

Interstitial lung disease endpoints

2.56

2.09

1.3

1.2

—

mmol/l

—

Malignant neoplasm of oral cavity

5.02

2.07

1.0

1.2

—

Disorder of lipoprotein metabolism, unspecified

2.91

2.07

1.0

1.1

—

Striking against or struck by other objects

168

1.73

2.06

1.3

1.5

—

1.82

mmol/l

—

Alzheimer disease, excluding more controls

5.56

2.06

1.2

1.0

—

Any dementia

2.08

2.06

1.1

—

mmol/l

—

Benign neoplasm: Cerebral meninges

3.50

2.05

1.0

1.3

—

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

288

1.53

2.04

1.1

1.3

—

2.31

mmol/l

—

Other disorders of kidney and ureter

2.50

2.01

1.2

—

mmol/l

—

Other interstitial pulmonary diseases

2.50

2.01

1.3

1.2

—

mmol/l

—

Other sleep disorders

2.63

2.01

1.4

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

3.34

1.96

1.0

1.3

—

Pneumococcal septicemia

4.56

1.94

1.0

1.5

—

Injury of nerves at wrist and hand level

4.56

1.94

1.0

1.2

—

mmol/l

—

Myocarditis

3.76

1.93

1.2

1.3

—

Familial hypercholesterolemia

2.65

1.86

1.1

—

mmol/l

—

Atherosclerosis, excluding cerebral and coronary sclerosis

108

1.78

1.84

1.0

1.2

—

mmol/l

—

Oesophagitis

3.54

1.84

2.0

1.1

—

mmol/l

—

Olecranon bursitis

3.05

1.80

1.1

1.5

—

Chronic ulcer of skin, not elsewhere classified

3.05

1.80

1.4

1.1

—

2.58

1.79

1.0

1.1

—

mmol/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

2.76

1.79

1.0

1.3

—

mmol/l

—

Arterial embolism and thrombosis

3.34

1.74

1.2

1.1

—

Tobacco use

2.92

1.72

1.0

1.4

—

Malignant neoplasm of head and neck

2.67

1.72

1.0

1.2

—

mmol/l

—

Cyst of kidney

2.92

1.72

1.3

1.4

—

mmol/l

—

Macular hole

3.85

1.71

1.0

1.2

—

Undefined dementia

3.83

1.69

1.0

1.2

—

Dementia

1.87

1.68

1.1

—

mmol/l

—

Other arrhythmias

209

1.50

1.67

1.1

1.4

—

1.55

mmol/l

—

Contact with nonpowered hand tool

3.17

1.66

1.0

1.1

—

Ill-defined and unknown causes of mortality

3.16

1.66

1.2

1.1

—

mmol/l

—

Cluster headache, strict

3.58

1.61

5.6

1.5

—

Other orthopaedic follow-up care

3.00

1.58

1.0

1.3

—

Unspecified dementia

3.47

1.55

1.0

—

Other symptoms and signs involving the urinary system

2.43

1.53

1.4

—

Cluster headache, wide

3.34

1.52

5.6

1.5

—

Other diseases of oesophagus

2.59

1.51

1.1

1.4

—

mmol/l

—

Nonischemic cardiomyopathy

2.86

1.50

1.0

1.3

—

mmol/l

—

Emphysema

2.86

1.50

1.0

1.3

—

mmol/l

—

Orchitis and epididymitis

2.44

1.47

1.1

1.3

—

Enlarged lymph nodes

2.43

1.47

1.4

1.2

—

mmol/l

—

Cardiomyopathies, Primary/intrinsic

2.22

1.46

1.0

1.3

—

mmol/l

—

Other symptoms and signs involving the digestive system and abdomen

2.37

1.45

1.2

—

mmol/l

—

Temporomandibular joint disorders

2.37

1.45

1.4

—

Benign neoplasm: Cerebral meninges

2.50

1.45

1.0

1.4

—

mmol/l

—

Panniculitis affecting regions of neck and back

3.13

1.44

1.0

1.3

—

Abnormal blood-pressure reading, without diagnosis

3.13

1.44

1.0

1.3

—

Unknown and unspecified causes of morbidity

2.73

1.43

1.3

—

Other disorders of penis

2.25

1.40

1.0

1.3

—

Palmar fascial fibromatosis [Dupuytren]

2.08

1.38

1.2

1.3

—

mmol/l

—

Adhesive capsulitis of shoulder

2.08

1.38

1.2

1.3

—

Other and unspecified abdominal hernia

2.95

1.36

1.0

1.6

—

Other and unspecified injuries of ankle and foot

2.95

1.36

1.2

1.6

—

Vascular disorders of the intestines

2.94

1.36

1.2

1.4

—

Non-allergic asthma (mode), excluding more controls

2.18

1.35

1.0

1.3

—

mmol/l

—

Parkinson's disease, strict definition

0.00

1.33

0.0

1.2

—

Cardiomyopathy (excluding other)

2.13

1.33

1.0

1.4

—

mmol/l

—

Other blood glucose lowering drugs, excl. Insulins

2.13

1.33

1.1

1.3

—

mmol/l

—

Sulfonylureas

1.73

1.32

1.0

1.2

—

mmol/l

—

Dementia in Alzheimer disease

2.57

1.32

1.0

—

Non-allergic asthma (mode)

2.07

1.28

1.0

1.3

—

mmol/l

—

Rubella [German measles]

2.78

1.28

1.2

1.4

—

mmol/l

—

Intestinal malabsorption

2.78

1.28

1.6

1.4

—

Other disorders of gingiva or/and edentulous alveolar ridge

2.78

1.28

1.0

—

Contusion of other and unspecified parts of foot

2.78

1.28

1.0

1.4

—

Subarachnoid haemorrhage

2.29

1.26

1.0

1.3

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

2.29

1.26

1.0

1.1

—

mmol/l

—

ILD, hospital admissions 1, main diag only

2.22

1.24

1.0

1.3

—

mmol/l

—

Trochanteric bursitis

2.22

1.24

1.0

1.3

—

Synovial cyst of popliteal space [Baker]

2.31

1.18

1.0

1.3

—

mmol/l

—

Unspecified misadventure during surgical and medical care

2.50

1.15

5.6

1.5

—

mmol/l

—

Intermittent heterotropia

2.50

1.15

1.2

1.5

—

Amiodarone users

2.26

1.10

1.1

1.3

—

Noninfective enteritis and colitis

217

1.43

1.10

1.2

1.4

—

1.75

mmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

2.38

1.09

1.4

1.5

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

2.38

1.09

1.0

1.2

—

Other and unspecified visual disturbances

2.19

1.08

1.1

1.2

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

2.18

1.07

1.0

1.1

—

mmol/l

—

Plantar fascial fibromatosis

2.12

1.05

1.3

—

mmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

253

1.32

1.05

1.1

1.3

—

1.62

mmol/l

—

Other diseases of stomach and duodenum

2.28

1.03

1.0

1.5

—

Other medical care

119

1.56

1.02

1.1

—

mmol/l

—

1.84

1.01

1.0

1.2

—

mmol/l

—

Other hammer toe(s) (acquired)

1.88

0.98

1.0

1.2

—

mmol/l

—

Benign neoplasm: Caecum

0.00

0.97

0.0

1.1

—

Vasomotor rhinitis (mode)

0.00

0.97

0.0

1.3

—

Benign neoplasm: Caecum

0.00

0.97

0.0

1.2

—

Injury of muscle and tendon at wrist and hand level

1.85

0.96

1.0

1.2

—

Ganglion

1.74

0.96

1.1

1.3

—

Colectomy operation

1.77

0.94

1.0

1.2

—

Oral leukoplakia and related diseases, including avohilmo

1.89

0.94

1.0

1.3

—

Care involving dialysis

2.22

0.93

1.0

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

280

1.27

0.91

1.1

1.3

—

1.62

mmol/l

—

Dementia, including avohilmo

1.52

0.90

1.1

—

mmol/l

—

Other infectious diseases

2.07

0.89

1.0

1.3

—

Ulcer of lower limb, not elsewhere classified

1.86

0.87

1.0

1.1

—

Nummular dermatitis

1.94

0.84

1.0

1.2

—

mmol/l

—

Chronic laryngitis and laryngotracheitis

1.74

0.82

1.1

—

Hyperparathyroidism

1.72

0.81

1.0

1.3

—

mmol/l

—

Other secondary gonarthrosis

0.00

0.79

0.0

1.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.82

0.79

1.0

1.3

—

mmol/l

—

Blepharochalasis

1.56

0.78

1.0

1.2

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

0.50

0.77

1.0

1.2

—

Other and unspecified vascular occlusions

0.00

0.77

0.0

1.3

—

Benign neoplasm: Ascending colon

1.77

0.76

1.2

1.1

—

Need for other prophylactic measures

2.09

0.74

1.0

1.4

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

2.08

0.74

1.0

1.2

—

mmol/l

—

Hydronephrosis

2.08

0.74

1.0

1.1

—

Fentanyl

2.08

0.74

1.2

1.3

—

Unspecified urinary incontinence

2.00

0.72

1.0

1.3

—

Perforation of tympanic membrane

1.80

0.72

1.0

1.3

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

328

1.21

0.71

1.1

1.2

—

1.79

mmol/l

—

Vasomotor and allergic rhinitis

180

0.66

0.71

1.0

1.2

—

Ankylosing spondylitis

1.75

0.71

1.3

—

mmol/l

—

Extracorporeal dialysis

1.93

0.70

1.0

1.4

—

Hypothyroidism, other/unspecified

280

1.23

0.69

1.1

1.3

—

1.62

mmol/l

—

Pneumothorax

1.85

0.68

1.2

1.4

—

Myocardial infarction, with ST-elevation

1.53

0.68

1.1

1.2

—

Adjustment and management of implanted device

1.59

0.65

1.1

1.2

—

mmol/l

—

Benign neoplasm: Transverse colon

1.73

0.64

1.4

1.2

—

mmol/l

—

Dental caries 2 and operation codes, only avohilmo

259

0.79

0.63

1.0

1.3

—

2.27

mmol/l

—

Viral pneumonia (unknown virus, not influenza)

1.67

0.61

1.0

1.3

—

Other diseases of arteries and capillaries

1.67

0.61

1.2

1.3

—

Other pleural conditions

1.67

0.61

1.0

1.3

—

AV-block

1.58

0.60

1.0

1.3

—

mmol/l

—

Inflammatory disease of cervix uteri

0.00

0.60

0.0

1.3

—

Ulcerative ileocolitis

0.00

0.59

0.0

1.5

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.59

0.0

1.1

—

Female infertility, associated with anovulation

0.00

0.58

0.0

1.0

—

Vitreous haemorrhage

1.67

0.56

1.0

1.3

—

Bronchitis, not specified as acute or chronic

1.58

0.54

1.0

1.2

—

Benign neoplasm: Ascending colon

1.58

0.54

1.2

1.3

—

Peripheral artery operations in Hilmo

1.50

0.51

1.0

1.3

—

Pacemaker

1.42

0.51

1.1

1.2

—

mmol/l

—

Cholecystitis

1.46

0.50

1.0

1.2

—

mmol/l

—

Pleural effusion

1.49

0.47

1.1

1.3

—

Polyarthropathies

230

1.19

0.45

1.1

1.3

—

1.94

mmol/l

—

Viral infections of the central nervous system

1.56

0.42

1.0

1.3

—

Chronic sinusitis

194

1.24

0.41

1.1

—

mmol/l

—

Benign neoplasm: Transverse colon

1.52

0.41

1.4

1.3

—

mmol/l

—

Metatarsalgia

1.52

0.41

1.0

1.3

—

Other articular cartilage disorders

0.00

0.41

0.0

1.5

—

Other dialysis

0.00

0.41

0.0

1.1

—

Other specified and unspecified retinal disorders

0.00

0.41

0.0

1.1

—

Golimumab

0.00

0.41

0.0

1.5

—

Other vitreous opacities

0.00

0.41

0.0

1.7

—

Melanocytic naevi of lower limb, including hip

0.00

0.41

0.0

1.2

—

Melanocytic naevi of lower limb, including hip

0.00

0.41

0.0

1.5

—

Malignant neoplasm of ovary

0.00

0.41

0.0

1.5

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

Bicuspidal aortic valve syndrome

0.00

0.41

0.0

1.3

—

Malignant neoplasm of mesothelium and soft tissue

0.00

0.41

0.0

1.4

—

Benign neoplasm: Skin of trunk

0.00

0.41

0.0

1.3

—

Malignant neoplasm of pancreas

0.00

0.41

0.0

1.1

—

Benign neoplasm: Skin of trunk

0.00

0.40

0.0

1.6

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.40

0.0

1.3

—

Other noninflammatory disorders of cervix uteri

0.00

0.40

0.0

1.1

—

Primary coxarthrosis, bilateral

1.36

0.40

1.1

1.2

—

mmol/l

—

Reimbursement for rheumatic diseases

259

0.81

0.39

1.1

1.3

—

1.66

mmol/l

—

Other enthesopathy of foot (+metatarsalgia)

1.43

0.39

1.0

1.3

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.39

0.0

1.4

—

Use of antiglaucoma preparations and miotics

0.00

0.39

0.0

1.5

—

L04AX Other immunosuppressants

259

0.81

0.39

1.0

1.3

—

1.76

mmol/l

—

Other disorders of bladder

1.39

0.38

1.2

1.1

—

Inflammatory diseases of prostate (prostatitis)

1.30

0.37

1.2

—

Abnormal spermatozoa

1.40

0.35

1.0

1.1

—

Dental caries 2, only avohilmo

328

0.87

0.34

1.0

1.3

—

2.12

mmol/l

—

Valvular operations

1.28

0.32

1.2

1.3

—

mmol/l

—

Thoracic aortic aneurysm

1.32

0.30

1.0

1.3

—

mmol/l

—

Endometriosis of ovary

1.32

0.30

1.4

1.1

—

mmol/l

—

Hallux rigidus

1.27

0.30

1.1

1.2

—

mmol/l

—

Dental caries 2

336

0.89

0.27

1.0

1.3

—

2.12

mmol/l

—

Colorectal cancer

0.69

0.26

1.0

1.3

—

ILD medications: immunosuppressive drugs

305

0.88

0.24

1.1

1.3

—

2.29

mmol/l

—

Achilles tendinitis

1.19

0.21

1.6

1.3

—

Other disorders of conjunctiva

1.19

0.21

1.0

1.1

—

Other specific arthropathies, wide

0.00

0.21

0.0

1.5

—

Hypertrichosis

0.00

0.21

0.0

1.8

—

IgA nephropathy (IgA glomerulonephritis)

0.00

0.21

0.0

1.2

—

Keratoconus

0.00

0.21

0.0

1.5

—

Corneal scars and opacities

0.00

0.21

0.0

1.5

—

Protozoal diseases

0.00

0.21

0.0

1.7

—

Hyperaldosteronism

0.00

0.21

0.0

1.5

—

Other and unspecified mononeuropathies of lower limb

0.00

0.21

0.0

1.5

—

Chorioretinal inflammation

0.00

0.21

0.0

1.9

—

Hodgkin lymphoma

0.00

0.21

0.0

1.5

—

Correction of physiology of bite - very demanding therapy visit

0.00

0.21

0.0

1.8

—

Systemic lupus erythematosus, unspecified

0.00

0.21

0.0

1.7

—

Nontoxic diffuse goitre

0.00

0.21

0.0

1.7

—

Benign neoplasm: Conjunctiva

0.00

0.21

0.0

1.3

—

Sixth [abducent] nerve palsy

0.00

0.21

0.0

1.7

—

Cystic kidney disease

0.00

0.21

0.0

1.7

—

Use of ropinirole

0.00

0.21

0.0

1.2

—

SLE, strict definition

0.00

0.21

0.0

1.7

—

SLE, ICD10

0.00

0.21

0.0

1.7

—

Melanoma in situ

0.00

0.21

0.0

1.2

—

Systemic lupus erythematosus

0.00

0.21

0.0

1.7

—

Subacute thyroiditis

0.00

0.21

0.0

1.7

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

0.21

0.0

1.2

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.21

0.0

1.7

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

0.21

0.0

1.2

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Use of selegiline

0.00

0.21

0.0

1.2

—

Other benign neoplasms of uterus

0.00

0.21

0.0

1.5

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

0.21

0.0

1.2

—

Erosion and ectropion of cervix uteri

0.00

0.21

0.0

1.0

—

Serous carcinoma of ovary

0.00

0.21

0.0

1.4

—

Other acute skin changes due to ultraviolet radiation

0.00

0.21

0.0

1.4

—

Melanoma in situ

0.00

0.21

0.0

1.2

—

L02BX Other hormone antagonists and related agents

0.00

0.21

0.0

1.2

—

Glaucoma-related operations

0.00

0.21

0.0

1.2

—

Chondromalacia

0.00

0.21

0.0

1.6

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.21

0.0

1.2

—

Peripheral retinal degeneration

0.00

0.21

0.0

1.6

—

Infections of breast associated with childbirth

0.00

0.21

0.0

1.6

—

Medial epicondylitis

0.00

0.21

0.0

1.5

—

Respiratory tuberculosis, confirmed and not-confirmed

0.00

0.21

0.0

1.2

—

Respiratory tuberculosis

0.00

0.21

0.0

1.2

—

Tuberculosis

0.00

0.21

0.0

1.2

—

Meralgia paraesthetica

0.00

0.20

0.0

1.6

—

Ulcerative enterocolitis

0.00

0.20

0.0

1.2

—

Diffuse large B-cell lymphoma

0.00

0.20

0.0

1.1

—

Female infertility, tubal origin

0.00

0.20

0.0

1.1

—

Second line medication for Crohn's disease

271

0.89

0.20

1.0

1.3

—

1.76

mmol/l

—

Disorders of the thyroid gland

308

1.08

0.18

1.1

1.3

—

1.53

mmol/l

—

Arthrosis

222

1.09

0.18

1.2

—

1.94

mmol/l

—

Dental caries 2 and operation codes

327

0.92

0.15

1.0

1.3

—

2.12

mmol/l

—

Disorders of breast

139

1.13

0.14

1.2

1.4

—

1.92

—

Disorders of sclera, cornea, iris and ciliary body

256

1.09

0.14

1.5

1.3

—

1.76

mmol/l

—

Actinic keratosis

103

0.83

0.13

1.0

1.1

—

mmol/l

—

Unspecific neurodegenerative disorder

1.17

0.12

1.2

1.1

—

Early lumbar disc prolapse, operated

1.14

0.10

1.2

1.3

—

mmol/l

—

Use of memantine

1.12

0.10

1.0

1.1

—

Use of other anti-dementia drugs

1.12

0.10

1.0

1.1

—

Deviated nasal septum

176

0.91

0.09

1.2

1.1

—

Lateral epicondylitis

1.11

0.09

1.2

1.3

—

Benign neoplasm: Rectum

1.07

0.08

1.2

—

Benign neoplasm: Rectum

1.05

0.08

1.2

—

Benign neoplasm: Sigmoid colon

1.05

0.08

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

107

0.88

0.08

1.0

1.1

—

mmol/l

—

N06DA Anticholinesterases

0.81

0.08

1.4

1.1

—

Use of anticholinesterases

0.81

0.08

1.4

1.1

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

0.77

0.08

1.4

1.0

—

mmol/l

—

Benign neoplasm: Rectum, anus and anal canal

1.04

0.08

1.3

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.04

0.08

1.3

1.2

—

115

0.90

0.07

1.0

1.1

—

mmol/l

—

Nasal polyp

0.82

0.07

1.0

1.2

—

mmol/l

—

Aortic aneurysm

1.04

0.07

1.0

1.2

—

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

302

1.04

0.05

1.0

1.3

—

1.79

mmol/l

—

Haemorrhoids and perianal venous thrombosis

100

1.10

0.05

1.1

1.2

—

mmol/l

—

Other enthesopathies

114

0.96

0.00

1.1

1.2

—

Alzheimer disease

0.90

0.00

1.2

1.1

—

Other specified/unspecified disorders of bone/cartilage

0.00

0.0

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.92

0.00

1.3

1.1

—

mmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.00

0.00

1.3

1.2

—

mmol/l

—

Other acute disseminated demyelination

0.00

0.0

1.6

—

Graves ophthalmopathy, strict

0.00

0.0

1.8

—

Other specified/unspecified deforming dorsopathies

0.00

0.0

1.7

—

Cytomegaloviral disease

0.00

0.0

1.6

—

Bruxism

0.00

0.0

2.0

—

Congenital malformations of breast

0.00

0.0

1.6

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

0.0

1.9

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.0

1.5

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.0

—

Autoimmune thyroiditis

0.00

0.0

1.4

—

Benign neoplasm: Lip

0.00

0.0

1.0

—

Benign neoplasm: Conjunctiva

0.00

0.0

2.3

—

Primary biliary cholangitis (PBC)

0.00

0.0

1.6

—

Arthropathy in ulcerative colitis

0.00

0.0

1.5

—

Benign neoplasm: Anus and anal canal

0.00

0.0

1.0

—

Lung cancer and mesothelioma

0.99

0.00

1.4

1.2

—

mmol/l

—

Other and unspecified nail disorders

0.00

0.0

1.7

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

0.0

1.3

—

Habitual aborter

0.00

0.0

1.0

—

Other and unspecified acne

0.00

0.0

1.0

—

Short Achilles tendon (acquired)

0.00

0.0

1.6

—

Venous complications and haemorrhoids in pregnancy

0.00

0.0

1.9

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

0.00

0.0

1.6

—

Complications associated with artificial fertilization

0.00

0.0

1.0

—

Use of fingolimod

0.00

0.0

1.6

—

Premenstrual syndrome

0.00

0.0

1.0

—

Use of teriflunomide

0.00

0.0

1.6

—

Hereditary retinal dystrophy

0.00

0.0

1.0

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.0

1.0

—

Hydatidiform mole

0.00

0.0

2.6

—

Placental disorders

0.00

0.0

1.6

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.0

1.3

—

Oral lichen ruber planus

0.00

0.0

1.6

—

Other abnormal immunological findings in serum

0.00

0.0

1.5

—

Epiphora

0.00

0.0

1.4

—

Crushing injury of wrist and hand

0.00

0.0

1.4

—

Injury of muscle and tendon at lower leg level

0.91

0.00

1.0

1.2

—

Cytomegalovirus infection, IBD co-morbidity

0.00

0.0

1.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

0.0

2.4

—

Contact with other hot metals

0.00

0.0

1.4

—

Exposure to other and unspecified man-made environmental factors

0.00

0.0

1.0

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.0

1.0

—

Special screening examination for neoplasms

0.00

0.0

1.3

—

Other melanin hyperpigmentation

0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Problems related to social environment

0.00

0.0

2.1

—

Melanocytic naevi of scalp and neck

0.00

0.0

1.8

—

Benign neoplasm: Sigmoid colon

0.98

0.00

1.2

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

1.4

—

Benign neoplasm: Vagina

0.00

0.0

1.6

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.0

1.3

—

Sexual dysfunction

0.00

0.0

1.0

—

Galactorrhea

0.00

0.0

2.6

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.0

1.8

—

Endometriosis of intestine

0.00

0.0

1.0

—

Other retinal artery occlusion

0.00

0.0

1.0

—

Family history of other conditions

0.00

0.0

1.0

—

Fistulae involving female genital tract

0.00

0.0

1.0

—

Other lesions of median nerve

0.00

0.0

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.0

2.0

—

Background retinopathy and retinal vascular changes

0.00

0.0

1.8

—

Idiopathic urticaria

0.00

0.0

1.6

—

Benign neoplasm: Vagina

0.00

0.0

2.3

—

Melanocytic naevi of scalp and neck

0.00

0.0

2.3

—

Disorders of globe

0.00

0.0

1.3

—

Alzheimer disease, including avohilmo

0.92

0.00

1.2

1.1

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.0

2.0

—

Thyroiditis, unspecified

0.00

0.0

2.3

—

Other benign neoplasms of uterus

0.00

0.0

1.0

—

Myeloid leukaemia

0.00

0.0

1.3

—

Hodgkin lymphoma, hilmo

0.00

0.0

1.6

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.0

1.4

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.7

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

CR(E)ST syndrome

0.00

0.0

2.0

—

Retinoschisis and retinal cysts

0.00

0.0

1.3

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Dissection of aorta

0.00

0.0

1.3

—

Diabetic neuropathy

0.96

0.00

1.0

1.2

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

Migraine without aura, drug-induced

0.00

0.0

1.6

—

Hirsutism in women

0.00

0.0

1.9

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.0

1.3

—

Other, unspecified and serous retinal detachments

0.00

0.0

1.3

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Non-Hodgkin lymphoma, all

0.00

0.0

1.4

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.5

—

Other/unspecified cytomegaloviral diseases

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Lip

0.00

0.0

1.8

—

Non-small cell lung cancer, squamous

0.00

0.0

1.3

—

Graves ophthalmopathy

0.00

0.0

1.7

—

Other assisted single delivery

0.00

0.0

1.9

—

Rare circulating lymphoid malignancy

0.00

0.0

1.3

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Viral agents as the cause of diseases classified to other chapters

0.00

0.0

1.5

—

Other overlap syndromes

0.00

0.0

1.6

—

Urethritis and urethral syndrome

0.00

0.0

1.0

—

Polycythaemia vera

0.00

0.0

1.3

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.0

1.6

—

Macular cyst

0.00

0.0

1.0

—

Respiratory tuberculosis, not confirmed

0.00

0.0

1.3

—

Myeloid leukaemia

0.00

0.0

1.3

—

Other disorders of iris and ciliary body

0.00

0.0

1.0

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

Other specified/unspecified spondylopathies

0.00

0.0

1.0

—

Pterygium

0.00

0.0

1.3

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

0.0

2.0

—

Cardiomyopathy, Hypertrophic obstructive

0.00

0.0

1.3

—

Chronic Coagulation defects

0.00

0.0

1.9

—

Oral leukoplakia, including avohilmo

0.00

0.0

1.0

—

Iliotibial band syndrome

0.00

0.0

2.0

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.3

—

Pathological resorption of teeth

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Isopropanol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS